Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction
- 1 October 1990
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 120 (4) , 855-863
- https://doi.org/10.1016/0002-8703(90)90201-8
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Effect of induced ventricular tachycardia on atrial natriuretic peptide in humansJournal of the American College of Cardiology, 1988
- Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmiasThe American Journal of Cardiology, 1988
- Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.Circulation, 1986
- Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardiaAmerican Heart Journal, 1986
- Antiarrhythmic drug efficacy at electrophysiology testing: Predictive effectiveness of procainamide and flecainideAmerican Heart Journal, 1986
- A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsThe Journal of Clinical Pharmacology, 1984
- Disopyramide: Evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillationThe American Journal of Cardiology, 1983
- Quinidine for ventricular arrhythmias: Value of electrophysiologic testingThe American Journal of Cardiology, 1983
- Prediction of response to class I antiarrhythmic drugs during electrophysiologic study of ventricular tachycardiaAmerican Heart Journal, 1982
- Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. B.American Heart Journal, 1975